All News
|
News Release
NIH-funded research effort identifies most common symptoms, potential subgroups, and initial symptom-based scoring system – with aim of improving future diagnostics and treatment Initial findings from a study of nearly 10,000 Americans, many of whom had COVID-19, have uncovered new details about long COVID, the post-infection set of conditions that...
Showing 10 out of 295 results
|
Media Availability
For Rare Disease Day 2022, NHLBI experts available to discuss rare heart, lung, and blood conditions
WHAT: To raise awareness about Rare Disease Day on February 28, researchers from the National Heart, Lung, and Blood Institute (NHLBI) are available to share updates about research designed to support people living with rare or uncommon heart, lung, and blood conditions. WHY: In the U.S., a condition is considered rare if it affects less than 200...
|
Media Availability
WHAT: After studying blood samples from 244 patients hospitalized for COVID-19, a group of researchers, including those who work at the National Institutes of Health, identified “rogue antibodies” that correlate with severe illness and may help explain mechanisms associated with severe blood clotting. The researchers found circulating...
|
Statement
PETAL Network study found no significant difference in 90-day mortality rates, nor safety concerns, after providing patients with one of two common treatment strategies Enrollment in a National Institutes of Health-supported trial with 1,563 patients being treated for sepsis at 60 U.S. medical centers ended early due to a lack of significant...
|
Media Availability
WHAT: Researchers have discovered new insights about lymphangioleiomyomatosis (LAM), a rare lung disease, which affects about 1 in 200,000 Americans and commonly features the growth of abnormal cells in different tissues and organs, including the lungs. As researchers studied LAM cells in the lab, they discovered a “mixed phenotype,” or differences...
|
Media Availability
NIH-wide initiative details efforts to advance sleep and circadian biology research WHAT: The National Institutes of Health’s Sleep Research Plan outlines five goals and nine critical research opportunities to advance sleep and circadian biology research. Key features of the plan focus on studying sleep and circadian mechanisms that underlie health...
|
News Release
Researchers have linked a rare genetic mutation found mostly in Black Americans and other people of African descent to an earlier onset of heart failure and a higher risk of hospitalization. The findings suggest that earlier screening for the mutation could lead to faster treatment and improved outcomes for heart failure in this vulnerable group...
|
News Release
A small clinical trial supported by the National Institutes of Health has found that eating during the nighttime—like many shift workers do—can increase glucose levels, while eating only during the daytime might prevent the higher glucose levels now linked with a nocturnal work life. The findings, the study authors said, could lead to novel...
|
News Release
NIH-funded study finds better short-term outcomes, but increased need for a pacemaker Patients with mitral and tricuspid valve regurgitation, a condition sometimes called “leaky heart valves,” appeared to do better after two years if they had a tricuspid valve repair at the time of mitral valve surgery, according to a study supported by the...
|
Media Advisory
Hoy se anunció que el Dr. Pérez-Stable y el Dr. Gibbons fueron los ganadores de la medalla de Respuesta al COVID-19 y que aceptarán este premio en una gala esta noche en Washington, D. C. Los líderes de los NIH encabezan dos importantes programas federales: RADx-UP y la Alianza de participación comunitaria (CEAL) contra las disparidades causadas...
|
Media Advisory
Today, the Partnership for Public Service awarded a Samuel J. Heyman Service to America Medal (the Sammies) to Dr. Gary H. Gibbons, director, National Heart, Lung, and Blood Institute (NHLBI) and Dr. Eliseo J. Pérez-Stable, director, National Institute on Minority Health and Health Disparities (NIMHD). The two received the COVID-19 Response medal...